FDA Inspection 857278 — Oxygen Development, L.L.C.

Oxygen Development, L.L.C. — FEI 3009461317

The FDA completed an inspection of Oxygen Development, L.L.C. on November 22, 2013 in Palm Springs, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palm Springs, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
136121 CFR 211.100(a)Absence of Written Procedures
363221 CFR 211.170(b)Annual visual exams of drug products